- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01662622
Minimal Alveolar Concentration of Sevoflurane Inducing Isoelectric Electroencephalogram
August 12, 2012 updated by: Wei Mei, Huazhong University of Science and Technology
Sevoflurane can abolish movement or adrenergic response to noxious stimulus.
In order to investigate the effect of sevoflurane on cerebral electrical activity, we determined the MAC of sevoflurane inducing isoelectric electroencephalogram (EEG) in 50% of the subjects (MACie) in middle aged subjects.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Patients received sevoflurane for anesthesia induction and maintenance at preselected concentrations according to an 'up and down' design, with 0.2% as a stepsize.
General anesthesia was induced and maintained with sevoflurane, tracheal intubation was facilitated with cisatracurium.
After a steady-state period of 30min without surgical stimulation, the state of isoelectric EEG was considered as significant when a burst suppression ratio of 100% last for more than 1 min.
The haemodynamic responses to skin incision and the vasopressor requirement to maintain cardiovascular system were also analysed according to the EEG state.
Study Type
Interventional
Enrollment (Actual)
31
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hubei
-
Wuhan, Hubei, China, 430030
- Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 45-65yr
- upper abdominal surgery in general anaesthesia
- ASA physical status classification of I or II
Exclusion Criteria:
- neurological disease
- received central nervous system-active drugs
- cardiac ejection fraction less than 40%
- history of difficult intubation or anticipated difficult intubation
- daily alcohol consumption
- obesity, defined as a body-mass index of more than 30
- without informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Sevoflurane
Anaesthesia was induced by 8% sevoflurane.
Cisatracurium 0.15mg kg-1 was administered after loss of the lash reflex, then ventilated manually until the amplitude of T1 decreased to 0. Intubation was performed and switched to mechanical ventilation with a fresh gas flow 2L min-1.
Gas concentrations were analysed using a gas analyser.The end-tidal concentration of carbon dioxide was maintained at 4.7kPa; an esophageal temperature probe was inserted and a warming unit was used if necessary to maintain normothermia (35.5°-38.5°).
The surgical incision was performed at least 30min after tracheal intubation.
When arterial blood pressure (MAP) decrease exceeding 20% of baseline values.
Phenylephrine 0.1mg was administered intravenously if necessary to maintained MAP and recorded.
|
The design of experiment is referred to the "Dixon up-and-down" method.
The first subject was designed to receive end-tidal sevoflurane concentration of 1.7%.
For each subject, 30 min interval time was given.
The isoelectric EEG was considered as significant when the isoelectric state last for more than 1min.
The maximal burst suppression rate was recorded if isoelectric EEG was not reached.
Heart rate and MAP, were recorded 2 and 1min before and 3 min after skin incision.
Adrenergic reflexes positive cases were counted.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MACie
Time Frame: 30min
|
Minimal Alveolar Concentration of sevoflurane inducing isoelectric electroencephalogram (EEG) in 50% of the subjects (MACie)
|
30min
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MACbs
Time Frame: 30 min
|
Minimal Alveolar Concentration of sevoflurane inducing inducing burst suppression EEG (MACbs) in middle aged adults.
|
30 min
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hemodynamic parameters
Time Frame: 3 min
|
Hemodynamic parameters 2 min before and 3 min after skin incision
|
3 min
|
Use of phenylephrine
Time Frame: 30 min
|
Use of phenylephrine during induction and maintenance of anesthesia with sevoflurane.
|
30 min
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2012
Primary Completion (Actual)
May 1, 2012
Study Completion (Actual)
July 1, 2012
Study Registration Dates
First Submitted
August 8, 2012
First Submitted That Met QC Criteria
August 9, 2012
First Posted (Estimate)
August 10, 2012
Study Record Updates
Last Update Posted (Estimate)
August 14, 2012
Last Update Submitted That Met QC Criteria
August 12, 2012
Last Verified
August 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TJMZK20120301
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sevoflurane
-
Inonu UniversityCompleted
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityRecruiting
-
Eye & ENT Hospital of Fudan UniversityEnrolling by invitation
-
Hospital General Universitario Gregorio MarañonCompleted
-
Tao ZhangUnknownSevoflurane | Cesarean Section | PropofolChina
-
Maharashtra University of Health SciencesJaslok Hospital and Research CentreCompletedMuscle Relaxation Caused by SevofluraneIndia
-
Mansoura UniversityCompletedElective Laparoscopic Cholecystectomy | Sevoflurane AnesthesiaEgypt
-
Sakarya UniversityCompletedSevoflurane | Anesthesia | MonitoringTurkey
-
Shanghai Ninth People's Hospital Affiliated to...UnknownEndotracheal Intubation | SevofluraneChina
-
Ohio State UniversityBaxter Healthcare CorporationCompletedSevoflurane | Cystoscopes | Baxter Anaesthesia Brand of DesfluraneUnited States
Clinical Trials on Sevoflurane
-
Yeungnam University College of MedicineCompleted
-
University of RostockCompletedOther Specified Injuries of Vocal Cord, SequelaGermany
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceTerminated
-
Kocaeli Derince Education and Research HospitalCompleted
-
Pontificia Universidad Catolica de ChileUnknown
-
Universiti Sains MalaysiaCompletedGeneral Anaesthesia | PaediatricsMalaysia
-
University Hospital, Clermont-FerrandCompleted
-
University Hospital, GhentCompleted
-
Signe Sloth MadsenCompletedHealthy Volunteers | General Anaesthesia | NeuroplasticityDenmark